Patent US1870997A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5484783A Expired / Lapsed US ⏱️ 0.0 years remaining

Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1994-03-24
•
Granted: 1996-01-16
•
Expires: 2014-03-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to the use of certain mercaptoacetylamide and benzazapine derivatives in treating patients suffering from hypertriglyceridemia, atherosclerosis and hypercholesterolemia.

Inventors

  • 👤 Gary A. Flynn
  • 👤 John F. French
  • 👤 Richard C. Dage

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 10:22
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55; A61P; A61P3/00; A61P3/06; A61P9/00; A61P9/10

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 207 words
A method of lowering total serum cholesterol in a patient in need thereof comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR4## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 2
Independent Claim 207 words
A method of lowering total serum cholesterol in a patient in need thereof comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR4## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 3
Independent Claim 202 words
A method of treating a patient for hypercholesterolemia comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR5## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 4
Independent Claim 202 words
A method of treating a patient for hypercholesterolemia comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR5## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 5
Independent Claim 206 words
A method of lowering plasma triglycerides in a patient in need thereof comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR6## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 6
Independent Claim 206 words
A method of lowering plasma triglycerides in a patient in need thereof comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR6## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 7
Independent Claim 203 words
A method of treating a patient suffering from hypertriglyceridemia comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR7## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 8
Independent Claim 203 words
A method of treating a patient suffering from hypertriglyceridemia comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR7## wherein A 1 and A 2 are each independently hydrogen or --COOR 4 wherein R 4 is hydrogen; --CH 2 O--C(O)C(CH 3 ) 3 ; a C 1 -C 4 alkyl; an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or diphenylmethyl; with the proviso that where A 1 is hydrogen, A 2 is --COOR 4 , and where A 1 is --COOR 4 , A 2 is hydrogen; B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; and n is an integer 0 or 1.
Claim 9
Independent Claim 193 words
A method of lowering total serum cholesterol in a patient in need thereof comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR8## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR9## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 10
Independent Claim 193 words
A method of lowering total serum cholesterol in a patient in need thereof comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR8## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR9## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 11
Independent Claim 188 words
A method of treating a patient for hypercholesterolemia comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR10## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR11## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 12
Independent Claim 188 words
A method of treating a patient for hypercholesterolemia comprising administering to said patient a therapeutically effective hypocholesterolemic amount of a compound of the Formula ##STR10## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR11## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 13
Independent Claim 192 words
A method of lowering plasma triglycerides in a patient in need thereof comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR12## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR13## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 14
Independent Claim 192 words
A method of lowering plasma triglycerides in a patient in need thereof comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR12## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR13## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 15
Independent Claim 189 words
A method of treating a patient suffering from hypertriglyceridemia comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR14## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR15## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 16
Independent Claim 189 words
A method of treating a patient suffering from hypertriglyceridemia comprising administering to said patient a therapeutically effective hypotriglyceridemic amount of a compound of the Formula ##STR14## wherein B 1 and B 2 are each independently hydrogen; hydroxy; --OR 5 wherein R 5 is a C 1 -C 4 alkyl or an Ar--Y-- group wherein Ar is aryl and Y is a C 0 -C 4 alkyl; or, where B 1 and B 2 are attached to adjacent carbon atoms, B 1 and B 2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; R 2 is hydrogen, C 1 -C 8 alkyl, --CH 2 OCH 2 CH 2 OCH 3 or an Ar--Y-- group; R 3 is hydrogen, acetyl, --CH 2 O--C(O)C(CH 3 ) 3 or benzoyl; R 4 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group, --CH 2 O--C(O)C(CH 3 ) 3 or diphenylmethyl; and ##STR15## wherein R 6 is hydrogen, a C 1 -C 4 alkyl or an Ar--Y-- group and R 7 is --CF 3 , a C 1 -C 10 alkyl or an Ar--Y-- group.
Claim 17
Independent Claim 16 words
A method according to any of claims 1-8 wherein the compound is [4S-[4α, 7α(R*), 12bβ]]-7-[(1-oxo-2(S)-acetylthio-3-phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo-pyrido[2,1-a][2]benzazepine-4-carboxylic acid.
Claim 18
Independent Claim 16 words
A method according to any of claims 1-8 wherein the compound is [4S-[4α, 7α(R*), 12bβ]]-7-[(1-oxo-2(S)-thio-3-phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxopyrido[2,1-a][2]benzazepine-4-carboxylic acid.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-01-15 1999-07-17 2000-01-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-01-15 2003-07-17 2004-01-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-01-15 2007-07-17 2008-01-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag